PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
26-Sep-2024 Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network Emmes
25-Sep-2024 Arctoris announces strategic partnership with Alphabet company, Isomorphic Labs Arctoris
25-Sep-2024 Univo IRB Launches Canadian Research Ethics Board Review Services for Clinical Trials in North America Univo IRB
25-Sep-2024 Quell Therapeutics expands manufacturing capabilities for CAR-Treg cell therapy pipeline through partnership with eXmoor pharma Quell Therapeutics
24-Sep-2024 Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider Phastar
24-Sep-2024 Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs Mabylon AG
23-Sep-2024 Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd
23-Sep-2024 Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Sanofi
23-Sep-2024 Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering Zenas BioPharma
23-Sep-2024 Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant Sanofi
23-Sep-2024 Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis AstraZeneca
23-Sep-2024 Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East Ondine Biomedical Inc
23-Sep-2024 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024 European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement The European Microbiome Innovation for Health
23-Sep-2024 Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Theriva™ Biologics, Inc.
19-Sep-2024 Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer Autolus Therapeutics plc
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems Biognosys
19-Sep-2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 Poolbeg Pharma plc
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA